Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics

Lin Ruan1, Guo-Liang Wang, Yan Chen

  • 1Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, 410008, Changsha, Hunan Province, China. rlin2008@sina.com

Insights

This study explored phosphoproteomics in nasopharyngeal carcinoma (NPC), identifying novel epidermal growth factor receptor (EGFR) signaling targets. Findings offer new insights into EGFR phosphorylation and potential NPC molecular cancer therapy.

Area of Science:

  • Oncology
  • Proteomics
  • Molecular Biology

Background:

  • Nasopharyngeal carcinoma (NPC) research has limited phosphoproteomics and oncogenic signaling analysis.
  • Epidermal growth factor receptor (EGFR) signaling is crucial in cancer, but its phosphotyrosine substrates in NPC require further elucidation.

Purpose of the Study:

  • To investigate the phosphotyrosine proteome in NPC cells stimulated with transforming growth factor alpha (TGF-α).
  • To identify novel downstream substrates of EGFR signaling in NPC.
  • To explore the implications of these findings for NPC molecular cancer therapy.

Main Methods:

  • Utilized 2-D electrophoresis (2-DE), 2-D western blotting, and mass spectrometry for functional proteomics.
  • Analyzed tyrosine phosphorylation levels of proteins in control versus TGF-α-treated CNE2 human NPC cells.
  • Validated novel EGFR signaling targets using immunoprecipitation (IP)-western blotting.

Main Results:

  • Identified and quantified 16 proteins with altered tyrosine phosphorylation levels in response to TGF-α.
  • Ten proteins showed increased tyrosine phosphorylation, while six showed decreased levels.
  • Confirmed ANXA3, KRT8, and KRT18 as novel tyrosine-phosphorylation targets within the EGFR signaling network.

Conclusions:

  • The study identified novel downstream substrates of EGFR signaling in NPC.
  • These findings enhance understanding of the complex EGFR phosphorylation network in NPC.
  • The identified targets may hold potential for future molecular cancer therapy strategies in NPC.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: